Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. Raisner R, Bainer R, Haverty PM, Benedetti KL, et al. PLoS One 2020;15:e0235343.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Raisner R, Bainer R, Haverty PM, Benedetti KL, et al. Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. PLoS One 2020;15:e0235343.
PMID: 32584896